Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis
- PMID: 24426
- PMCID: PMC1000200
- DOI: 10.1136/ard.37.1.93
Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis
Abstract
Forty-six patients with rheumatoid arthritis, 22 receiving D-penicillamine and 2j alclofenac, took part in a 6-month single-bind external observer trial to compare the efficacy and toxicity of these drugs in the treatment of severe rheumatoid arthritis. Both drugs were active and similar in their efficacy at 6 months as judged by clinical and laboratory measurements. Penicillamine was active therapeutically by 3 months, one month before alclofenac. 9 patients, 8 on alclofenac and one on D-penicillamine, had to stop treatment because of lack of effect or toxic effects. Skin rashes within the first week of treatment were a major problem with alclofenac and led to 6 withdrawals.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
